SCYNEXIS, Inc. (NASDAQ: SCYX) is a biotechnology company pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant fungal infections.

Biotechnology

SCYNEXIS

SCYNEXIS' headquarters in Jersey City, NJ, United States

David Angulo

Jitka Shavel

Jeff Clark

Lori Tierney

Rossana Ferrara-Pontoriero

Daniella Gigante

Ivor Macleod

Scott Sukenick

Guy Macdonald

Ann F. Hanham

Armando Anido

David Hastings

Philippe Tinmouth

Steven C. Gilman

The Leadership Team at SCYNEXIS is responsible for setting the strategic direction of the company and ensuring alignment with its mission to develop innovative therapies for difficult-to-treat infections. This team, comprising the President & CEO and the Chief Legal Officer, oversees operational, legal, and regulatory aspects of the business, fostering collaboration across all functions to drive the success and growth of SCYNEXIS in the biotechnology sector.

Leadership Team

This department provides strategic direction and oversight for the organization.

Leadership Council

The Sales team at SCYNEXIS is responsible for driving revenue growth by promoting and selling innovative antifungal therapies to healthcare providers and institutions. They focus on building strong relationships with key stakeholders, educating them about the benefits of SCYNEXIS products, and addressing the growing challenge of drug-resistant infections. This team collaborates closely with marketing to align messaging and maximize outreach efforts, particularly in specialty and women's health sectors.

Sales

The Clinical Operations and Medical Affairs team at SCYNEXIS is responsible for overseeing the planning and execution of clinical trials, ensuring adherence to regulatory standards, and facilitating collaboration between clinical and medical teams. They engage with healthcare professionals to disseminate scientific information and gather insights to support the development and commercialization of innovative antifungal therapies. This team plays a crucial role in advancing SCYNEXIS’s mission to address drug-resistant infections through effective communication and operational excellence in clinical development.

Clinical Operations and Medical Affairs

The Finance and Accounting team at SCYNEXIS is responsible for managing the company's financial health, ensuring accurate reporting, and compliance with regulatory standards. This includes budgeting, forecasting, and financial analysis to support strategic decision-making, as well as overseeing accounting operations to maintain integrity in financial reporting. The team plays a crucial role in funding the development of innovative treatments for drug-resistant infections.

Finance and Accounting

This department oversees the planning, execution, and management of clinical trials to ensure compliance and efficiency in research processes.

SCYNEXIS

Org chart

Board & advisors

Teams

Leadership Team

Leadership Council

Sales

Clinical Operations and Medical Affairs

Finance and Accounting

Clinical Trials

Offices

SCYNEXIS

Org chart

Board & advisors

Teams

Leadership Team

Leadership Council

Sales

Clinical Operations and Medical Affairs

Finance and Accounting

Clinical Trials

Offices

Related companies